Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center

INTRODUCTION: Medullary thyroid carcinoma (MTC) is a rare cancer that accounts for 5% of thyroid cancers. Serum calcitonin is a good biomarker for MTC, which is used for diagnosis, prognosis, and monitoring of recurrence. Calcitonin-negative MTC (CNMTC) is rare but confounds diagnostic and prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sun Jung, Yun, Hyeok Jun, Shin, Su-Jin, Lee, Yong Sang, Chang, Hang-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602843/
https://www.ncbi.nlm.nih.gov/pubmed/34803914
http://dx.doi.org/10.3389/fendo.2021.747704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602843/
https://www.ncbi.nlm.nih.gov/pubmed/34803914
http://dx.doi.org/10.3389/fendo.2021.747704

Ejemplares similares